267 related articles for article (PubMed ID: 24951229)
1. LI-RADS categorization of benign and likely benign findings in patients at risk of hepatocellular carcinoma: a pictorial atlas.
Jha RC; Mitchell DG; Weinreb JC; Santillan CS; Yeh BM; Francois R; Sirlin CB
AJR Am J Roentgenol; 2014 Jul; 203(1):W48-69. PubMed ID: 24951229
[TBL] [Abstract][Full Text] [Related]
2. Differences in Liver Imaging and Reporting Data System Categorization Between MRI and CT.
Corwin MT; Fananapazir G; Jin M; Lamba R; Bashir MR
AJR Am J Roentgenol; 2016 Feb; 206(2):307-12. PubMed ID: 26797357
[TBL] [Abstract][Full Text] [Related]
3. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
Quaia E; Pizzolato R; De Paoli L; Angileri R; Ukmar M; Cova MA
J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
[TBL] [Abstract][Full Text] [Related]
4. Cirrhotic liver: What's that nodule? The LI-RADS approach.
Shah A; Tang A; Santillan C; Sirlin C
J Magn Reson Imaging; 2016 Feb; 43(2):281-94. PubMed ID: 25996905
[TBL] [Abstract][Full Text] [Related]
5. Liver Imaging Reporting and Data System:: Substantial Discordance Between CT and MR for Imaging Classification of Hepatic Nodules.
Zhang YD; Zhu FP; Xu X; Wang Q; Wu CJ; Liu XS; Shi HB
Acad Radiol; 2016 Mar; 23(3):344-52. PubMed ID: 26777590
[TBL] [Abstract][Full Text] [Related]
6. Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.
Darnell A; Forner A; Rimola J; Reig M; García-Criado Á; Ayuso C; Bruix J
Radiology; 2015 Jun; 275(3):698-707. PubMed ID: 25658038
[TBL] [Abstract][Full Text] [Related]
7. LI-RADS (Liver Imaging Reporting and Data System): summary, discussion, and consensus of the LI-RADS Management Working Group and future directions.
Mitchell DG; Bruix J; Sherman M; Sirlin CB
Hepatology; 2015 Mar; 61(3):1056-65. PubMed ID: 25041904
[TBL] [Abstract][Full Text] [Related]
8. From the RSNA refresher courses: screening the cirrhotic liver for hepatocellular carcinoma with CT and MR imaging: opportunities and pitfalls.
Baron RL; Peterson MS
Radiographics; 2001 Oct; 21 Spec No():S117-32. PubMed ID: 11598252
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm.
Ronot M; Fouque O; Esvan M; Lebigot J; Aubé C; Vilgrain V
J Hepatol; 2018 Apr; 68(4):715-723. PubMed ID: 29274407
[TBL] [Abstract][Full Text] [Related]
10. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
11. CT and MRI findings of cirrhosis-related benign nodules with ischaemia or infarction after variceal bleeding.
Kim YK; Park G; Kim CS; Han YM
Clin Radiol; 2010 Oct; 65(10):801-8. PubMed ID: 20797466
[TBL] [Abstract][Full Text] [Related]
12. Classifying CT/MR findings in patients with suspicion of hepatocellular carcinoma: Comparison of liver imaging reporting and data system and criteria-free Likert scale reporting models.
Zhang YD; Zhu FP; Xu X; Wang Q; Wu CJ; Liu XS; Shi HB
J Magn Reson Imaging; 2016 Feb; 43(2):373-83. PubMed ID: 26119393
[TBL] [Abstract][Full Text] [Related]
13. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging.
Matsui O; Kadoya M; Kameyama T; Yoshikawa J; Arai K; Gabata T; Takashima T; Nakanuma Y; Terada T; Ida M
Radiology; 1989 Oct; 173(1):123-6. PubMed ID: 2550995
[TBL] [Abstract][Full Text] [Related]
14. Understanding LI-RADS: a primer for practical use.
Santillan CS; Tang A; Cruite I; Shah A; Sirlin CB
Magn Reson Imaging Clin N Am; 2014 Aug; 22(3):337-52. PubMed ID: 25086933
[TBL] [Abstract][Full Text] [Related]
15. Update on the Liver Imaging Reporting and Data System: What the Pathologist Needs to Know.
Tang A; Valasek MA; Sirlin CB
Adv Anat Pathol; 2015 Sep; 22(5):314-22. PubMed ID: 26262514
[TBL] [Abstract][Full Text] [Related]
16. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features.
Hanna RF; Aguirre DA; Kased N; Emery SC; Peterson MR; Sirlin CB
Radiographics; 2008; 28(3):747-69. PubMed ID: 18480482
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: imaging spectrum and pitfalls of cirrhosis-related nodules.
Jeong YY; Yim NY; Kang HK
AJR Am J Roentgenol; 2005 Oct; 185(4):1024-32. PubMed ID: 16177427
[TBL] [Abstract][Full Text] [Related]
18. Increased interreader agreement in diagnosis of hepatocellular carcinoma using an adapted LI-RADS algorithm.
Becker AS; Barth BK; Marquez PH; Donati OF; Ulbrich EJ; Karlo C; Reiner CS; Fischer MA
Eur J Radiol; 2017 Jan; 86():33-40. PubMed ID: 28027763
[TBL] [Abstract][Full Text] [Related]
19. T2-weighted MR imaging in the assessment of cirrhotic liver.
Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
[TBL] [Abstract][Full Text] [Related]
20. Infarcted regenerative nodules in cirrhosis: CT and MR imaging findings with pathologic correlation.
Kim T; Baron RL; Nalesnik MA
AJR Am J Roentgenol; 2000 Oct; 175(4):1121-5. PubMed ID: 11000176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
